Aerie pharmaceuticals receives positive chmp opinion for roclanda® in the european union

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases, today announced the european medicines agency's (ema) committee for medicinal products for human use (chmp) has adopted a positive opinion recommending approval of the marketing authorisation appli
AERI Ratings Summary
AERI Quant Ranking